Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
Diabetes News
Clinical trials testing therapies for diabetes
Latest Top (15) News
Food Resource Equity and Sustainability for Health Conditions: BMI; Blood Pressure Intervention: Behavioral: healthy eating and gardening Sponsor: University of Oklahoma Not yet recruiting - verified August 2017
Mon, 14 Aug 2017 12:00:00 EDT Pediatrics Owning Performance Study Condition: Diabetes Mellitus, Type 1 Intervention: Device: Pops! One personalized mobile platform Sponsors: Children's Hospitals and Clinics of Minnesota; Pops! Diabetes Care Recruiting - verified August 2017
Mon, 14 Aug 2017 12:00:00 EDT Exercise Using Chinese Yoga Improving Insomnia Condition: Exercise Promotion Intervention: Behavioral: Yoga Sponsor: Taichung Veterans General Hospital Recruiting - verified August 2017
Sun, 13 Aug 2017 12:00:00 EDT Cardiovascular Outcomes in Participants With Type 2 Diabetes Mellitus (T2DM) Condition: Diabetes Mellitus, Type 2 Interventions: Drug: Canagliflozin; Drug: Empagliflozin; Drug: Dapagliflozin; Drug: Dipeptidyl Peptidase-4 Inhibitor (DPP-4); Drug: Glucagon-Like Peptide-1 Agonist (GLP-1); Drug: Thiazolidinedione (TZD); Drug: Sulfonylureas; Drug: Insulin Sponsor: Janssen Research & Development, LLC Active, not recruiting - verified August 2017
Thu, 10 Aug 2017 12:00:00 EDT E-Cigarette Inner City RCT Conditions: Tobacco Dependence; COPD Asthma; Mental Illness; Substance Use Intervention: Device: Improved Quality of Life of low-income Canadians that smoke tobacco and other substances Sponsor: Ottawa Hospital Research Institute Not yet recruiting - verified August 2017
Wed, 09 Aug 2017 12:00:00 EDT Efficacy of Platelet Rich Plasma Injection in Diabetic Neuropathy Condition: Diabetic Peripheral Neuropathy Interventions: Drug: PRP injection; Other: traditional medical treatment Sponsor: Assiut University Recruiting - verified August 2017
Tue, 08 Aug 2017 12:00:00 EDT Project Powerfood: Promoting Food Security, Equity, and Health Conditions: Diabetes; Obesity Interventions: Other: Autumn Group; Other: Spring Group Sponsors: Icahn School of Medicine at Mount Sinai; New York Common Pantry; Corbin Hill Food Project; Wholesome Wave Recruiting - verified August 2017
Tue, 08 Aug 2017 12:00:00 EDT
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.
Latest Top (10) News
FDA warns of potential contamination in multiple brands of drugs, dietary supplements The U.S. Food and Drug Administration is advising consumers and health care professionals not to use any liquid drug or dietary supplement products manufactured by PharmaTech LLC of Davie, Florida, and labeled by Rugby Laboratories, Major Pharmaceuticals and Leader Brands, due to potential contamination with the bacteria Burkholderia cepacia (B. cepacia) and the risk for severe patient infection.
Fri, 11 Aug 2017 15:34:00 -0400 FDA to expand public education campaign to focus on prevention of youth e-cigarette use Today, the U.S. Food and Drug Administration announced it would pursue a strategic, new public health education campaign aimed at discouraging the use of e-cigarettes and other electronic nicotine delivery systems (ENDS) by kids. The agency plans to expand its “The Real Cost” public education campaign to include messaging to teens about the dangers of using these products this fall while developing a full-scale campaign to launch in 2018. These efforts are part of the agency’s new comprehensive plan for tobacco and nicotine regulation, as well as ongoing efforts to educate youth about, and protect them from, the dangers associated with using all tobacco products. It is the first time the FDA will be utilizing public health education to specifically target youth use of e-cigarettes or other ENDS.
Tue, 08 Aug 2017 10:00:00 -0400 Federal judge enters consent decree against outsourcing facility Isomeric Pharmacy Solutions U.S. District Judge Robert J. Shelby entered a consent decree of permanent injunction yesterday between the United States and Isomeric Pharmacy Solutions of Salt Lake City, Utah, two of the company’s co-owners, William O. Richardson and Rachael S. Cruz, and chief operating officer Jeffery D. Brown.
Fri, 04 Aug 2017 10:17:00 -0400 FDA approves Mavyret for Hepatitis C The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis. Mavyret is also approved for adult patients with HCV genotype 1 infection who have been previously treated with a regimen either containing an NS5A inhibitor or an NS3/4A protease inhibitor but not both.
Thu, 03 Aug 2017 15:06:00 -0400 FDA approves first treatment for certain types of poor-prognosis acute myeloid leukemia The U.S. Food and Drug Administration today approved Vyxeos for the treatment of adults with two types of acute myeloid leukemia (AML): newly diagnosed therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC). Vyxeos is a fixed-combination of chemotherapy drugs daunorubicin and cytarabine.
Thu, 03 Aug 2017 09:09:00 -0400 FDA approves treatment for chronic graft versus host disease The U.S. Food and Drug Administration today expanded the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) after failure of one or more treatments. This is the first FDA-approved therapy for the treatment of cGVHD.
Wed, 02 Aug 2017 11:30:00 -0400 FDA approves new targeted treatment for relapsed or refractory acute myeloid leukemia The U.S. Food and Drug Administration today approved Idhifa (enasidenib) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation. The drug is approved for use with a companion diagnostic, the RealTime IDH2 Assay, which is used to detect specific mutations in the IDH2 gene in patients with AML.
Tue, 01 Aug 2017 11:10:00 -0400 FDA announces comprehensive regulatory plan to shift trajectory of tobacco-related disease, death The U.S. Food and Drug Administration today announced a new comprehensive plan for tobacco and nicotine regulation that will serve as a multi-year
roadmap to better protect kids and significantly reduce tobacco-related disease and death. The approach places nicotine, and the issue of addiction,
at the center of the agency’s tobacco regulation efforts. The goal is to ensure that the FDA has the proper scientific and regulatory foundation to
efficiently and effectively implement the Family Smoking Prevention and Tobacco Control Act. To make certain that the FDA is striking an appropriate
balance between regulation and encouraging development of innovative tobacco products that may be less dangerous than cigarettes, the agency is also
providing targeted relief on some timelines described in the May 2016 final rule that extended the FDA’s authority to additional tobacco products.
The agency will also seek input on critical public health issues such as the role of flavors in tobacco products.
Fri, 28 Jul 2017 09:55:00 -0400 FDA clears first neonatal magnetic resonance imaging device Today, the U.S. Food and Drug Administration cleared the first magnetic resonance imaging (MRI) device specifically for neonatal brain and head imaging in neonatal intensive care units (NICU).
Thu, 20 Jul 2017 13:44:00 -0400 Statement from FDA Commissioner Scott Gottlieb, M.D., on the Funding Awards to States for FDA Food Safety Modernization Act (FSMA) Produce Safety Implementation More than 3,000 Americans are estimated to die each year from foodborne illnesses and many more are hospitalized and sickened. Yet most of these illnesses and deaths are preventable. While the U.S. has one of the safest food supplies in the world, Congress entrusted the FDA with new authorities and resources – as part of the FDA Food Safety Modernization Act (FSMA) – to update and strengthen the FDA’s risk-based approach to the oversight of food safety.
Wed, 19 Jul 2017 09:46:00 -0400
Diabetes news from the American Diabetes Association
